Viewing Study NCT00210756

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:21 PM
Ignite Modification Date: 2026-01-03 @ 7:47 PM
Study NCT ID: NCT00210756
Status: COMPLETED
Last Update Posted: 2011-06-10
First Post: 2005-09-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Pharmacokinetic/ Pharmacodynamic Study of Epoetin Alfa (PROCRIT) in Critically Ill Patients.
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anemia View
None Critical Illness View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Anemia View
None pharmacokinetics View
None erythropoetin View
None Epoetin alfa View
None erythropoetin recombinant View
None Critical care View
None critical illness, intensive care, View